Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116039248> ?p ?o ?g. }
- W2116039248 endingPage "1178" @default.
- W2116039248 startingPage "1162" @default.
- W2116039248 abstract "Tumor cell invasion is the principal cause of treatment failure and death among patients with malignant gliomas. Connective tissue growth factor (CTGF) has been previously implicated in cancer metastasis and invasion in various tumors. We explored the mechanism of CTGF-mediated glioma cell infiltration and examined potential therapeutic targets. Highly infiltrative patient-derived glioma tumor–initiating or tumor stem cells (TIC/TSCs) were harvested and used to explore a CTGF-induced signal transduction pathway via luciferase reporter assays, chromatin immunoprecipitation (ChIP), real-time polymerase chain reaction, and immunoblotting. Treatment of TIC/TSCs with small-molecule inhibitors targeting integrin β1 (ITGB1) and the tyrosine kinase receptor type A (TrkA), and short hairpin RNAs targeting CTGF directly were used to reduce the levels of key protein components of CTGF-induced cancer infiltration. TIC/TSC infiltration was examined in real-time cell migration and invasion assays in vitro and by immunohistochemistry and in situ hybridization in TIC/TSC orthotopic xenograft mouse models (n = 30; six mice per group). All statistical tests were two-sided. Treatment of TIC/TSCs with CTGF resulted in CTGF binding to ITGB1–TrkA receptor complexes and nuclear factor kappa B (NF-κB) transcriptional activation as measured by luciferase reporter assays (mean relative luciferase activity, untreated vs CTGF 200 ng/mL : 0.53 vs 1.87, difference = 1.34, 95% confidence interval [CI] = 0.69 to 2, P < .001). NF-κB activation resulted in binding of ZEB-1 to the E-cadherin promoter as demonstrated by ChIP analysis with subsequent E-cadherin suppression (fold increase in ZEB-1 binding to the E-cadherin promoter region: untreated + ZEB-1 antibody vs CTGF 200 ng/mL + ZEB-1 antibody: 1.5 vs 6.4, difference = 4.9, 95% CI = 4.8 to 5.0, P < .001). Immunohistochemistry and in situ hybridization revealed that TrkA is selectively expressed in the most infiltrative glioma cells in situ and that the surrounding reactive astrocytes secrete CTGF. A CTGF-rich microenvironment facilitates CTGF–ITGB1–TrkA complex activation in TIC/TSCs, thereby increasing the invasiveness of malignant gliomas." @default.
- W2116039248 created "2016-06-24" @default.
- W2116039248 creator A5005161415 @default.
- W2116039248 creator A5010108216 @default.
- W2116039248 creator A5032225706 @default.
- W2116039248 creator A5039396196 @default.
- W2116039248 creator A5045925835 @default.
- W2116039248 creator A5056721103 @default.
- W2116039248 creator A5069316485 @default.
- W2116039248 creator A5076189170 @default.
- W2116039248 creator A5080479135 @default.
- W2116039248 creator A5081985656 @default.
- W2116039248 creator A5087403626 @default.
- W2116039248 creator A5088565485 @default.
- W2116039248 creator A5090559830 @default.
- W2116039248 date "2011-07-19" @default.
- W2116039248 modified "2023-10-15" @default.
- W2116039248 title "Effect of Brain- and Tumor-Derived Connective Tissue Growth Factor on Glioma Invasion" @default.
- W2116039248 cites W14817136 @default.
- W2116039248 cites W1536266814 @default.
- W2116039248 cites W1753428747 @default.
- W2116039248 cites W1970448164 @default.
- W2116039248 cites W1980679659 @default.
- W2116039248 cites W1983426119 @default.
- W2116039248 cites W1985749328 @default.
- W2116039248 cites W1987085702 @default.
- W2116039248 cites W1994195248 @default.
- W2116039248 cites W1994901446 @default.
- W2116039248 cites W1999512677 @default.
- W2116039248 cites W1999737406 @default.
- W2116039248 cites W2001544973 @default.
- W2116039248 cites W2018671779 @default.
- W2116039248 cites W2030194693 @default.
- W2116039248 cites W2037831105 @default.
- W2116039248 cites W2055343221 @default.
- W2116039248 cites W2059158933 @default.
- W2116039248 cites W2060551076 @default.
- W2116039248 cites W2060810914 @default.
- W2116039248 cites W2064717645 @default.
- W2116039248 cites W2066607735 @default.
- W2116039248 cites W2071494495 @default.
- W2116039248 cites W2073179267 @default.
- W2116039248 cites W2080243787 @default.
- W2116039248 cites W2084980673 @default.
- W2116039248 cites W2087963453 @default.
- W2116039248 cites W2096287682 @default.
- W2116039248 cites W2110898038 @default.
- W2116039248 cites W2111380872 @default.
- W2116039248 cites W2124078079 @default.
- W2116039248 cites W2128066516 @default.
- W2116039248 cites W2132257102 @default.
- W2116039248 cites W2135376726 @default.
- W2116039248 cites W2148576723 @default.
- W2116039248 cites W2165753394 @default.
- W2116039248 cites W2169804478 @default.
- W2116039248 cites W2326889571 @default.
- W2116039248 cites W4256062813 @default.
- W2116039248 doi "https://doi.org/10.1093/jnci/djr224" @default.
- W2116039248 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3149042" @default.
- W2116039248 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21771732" @default.
- W2116039248 hasPublicationYear "2011" @default.
- W2116039248 type Work @default.
- W2116039248 sameAs 2116039248 @default.
- W2116039248 citedByCount "107" @default.
- W2116039248 countsByYear W21160392482012 @default.
- W2116039248 countsByYear W21160392482013 @default.
- W2116039248 countsByYear W21160392482014 @default.
- W2116039248 countsByYear W21160392482015 @default.
- W2116039248 countsByYear W21160392482016 @default.
- W2116039248 countsByYear W21160392482017 @default.
- W2116039248 countsByYear W21160392482018 @default.
- W2116039248 countsByYear W21160392482019 @default.
- W2116039248 countsByYear W21160392482020 @default.
- W2116039248 countsByYear W21160392482021 @default.
- W2116039248 countsByYear W21160392482022 @default.
- W2116039248 countsByYear W21160392482023 @default.
- W2116039248 crossrefType "journal-article" @default.
- W2116039248 hasAuthorship W2116039248A5005161415 @default.
- W2116039248 hasAuthorship W2116039248A5010108216 @default.
- W2116039248 hasAuthorship W2116039248A5032225706 @default.
- W2116039248 hasAuthorship W2116039248A5039396196 @default.
- W2116039248 hasAuthorship W2116039248A5045925835 @default.
- W2116039248 hasAuthorship W2116039248A5056721103 @default.
- W2116039248 hasAuthorship W2116039248A5069316485 @default.
- W2116039248 hasAuthorship W2116039248A5076189170 @default.
- W2116039248 hasAuthorship W2116039248A5080479135 @default.
- W2116039248 hasAuthorship W2116039248A5081985656 @default.
- W2116039248 hasAuthorship W2116039248A5087403626 @default.
- W2116039248 hasAuthorship W2116039248A5088565485 @default.
- W2116039248 hasAuthorship W2116039248A5090559830 @default.
- W2116039248 hasBestOaLocation W21160392481 @default.
- W2116039248 hasConcept C126322002 @default.
- W2116039248 hasConcept C142724271 @default.
- W2116039248 hasConcept C153911025 @default.
- W2116039248 hasConcept C170493617 @default.
- W2116039248 hasConcept C2775960820 @default.
- W2116039248 hasConcept C2778227246 @default.
- W2116039248 hasConcept C2780631158 @default.